Personalized medicine startup Bioarray Genetics fetches $4 mln Series B

Bioarray Genetics, a personalized medicine startup, has raised $4 million in Series B funding. The investors were Quark Venture and GF Securities.

5 October 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail